Handelsbanken Fonder’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $17.6M | Sell |
262,070
-7,441
| -3% | -$496K | 0.05% | 294 |
|
|
2026
Q1 | $16.9M | Sell |
269,511
-50,613
| -16% | -$3.52M | 0.06% | 265 |
|
|
2025
Q4 | $21.2M | Sell |
320,124
-230,974
| -42% | -$14.9M | 0.06% | 253 |
|
|
2025
Q3 | $37.1M | Buy |
551,098
+66,713
| +14% | +$5.28M | 0.12% | 161 |
|
|
2025
Q2 | $42.3M | Buy |
484,385
+267,118
| +123% | +$20.9M | 0.15% | 128 |
|
|
2025
Q1 | $14.8M | Buy |
217,267
+1,529
| +0.7% | +$125K | 0.06% | 274 |
|
|
2024
Q4 | $16.8M | Buy |
215,738
+51,275
| +31% | +$3.8M | 0.06% | 274 |
|
|
2024
Q3 | $11M | Sell |
164,463
-265,677
| -62% | -$21.8M | 0.04% | 336 |
|
|
2024
Q2 | $48.8M | Sell |
430,140
-21,110
| -5% | -$2.67M | 0.21% | 96 |
|
|
2024
Q1 | $62.6M | Buy |
451,250
+11,259
| +3% | +$1.42M | 0.27% | 79 |
|
|
2023
Q4 | $54.6M | Sell |
439,991
-24,615
| -5% | -$2.51M | 0.27% | 83 |
|
|
2023
Q3 | $43.3M | Buy |
464,606
+45,735
| +11% | +$5.16M | 0.24% | 91 |
|
|
2023
Q2 | $53.8M | Buy |
418,871
+45,001
| +12% | +$5.44M | 0.29% | 73 |
|
|
2023
Q1 | $43.4M | Sell |
373,870
-24,983
| -6% | -$2.8M | 0.25% | 93 |
|
|
2022
Q4 | $45.2M | Buy |
398,853
+19,431
| +5% | +$2.13M | 0.28% | 84 |
|
|
2022
Q3 | $30.6M | Buy |
379,422
+6,958
| +2% | +$589K | 0.2% | 120 |
|
|
2022
Q2 | $27.8M | Buy |
372,464
+119,228
| +47% | +$10.9M | 0.18% | 132 |
|
|
2022
Q1 | $32.4M | Sell |
253,236
-40,352
| -14% | -$4.41M | 0.18% | 126 |
|
|
2021
Q4 | $39.4M | Sell |
293,588
-53,020
| -15% | -$7.62M | 0.19% | 126 |
|
|
2021
Q3 | $47.4M | Buy |
346,608
+17,992
| +5% | +$2.27M | 0.25% | 92 |
|
|
2021
Q2 | $35.1M | Buy |
328,616
+16,900
| +5% | +$1.62M | 0.18% | 125 |
|
|
2021
Q1 | $28M | Buy |
311,716
+4,912
| +2% | +$461K | 0.16% | 140 |
|
|
2020
Q4 | $28.4M | Buy |
306,804
+74,072
| +32% | +$6.61M | 0.17% | 132 |
|
|
2020
Q3 | $24M | Buy |
232,732
+21,600
| +10% | +$2.26M | 0.18% | 123 |
|
|
2020
Q2 | $21.4M | Buy |
211,132
+119,132
| +129% | +$10.7M | 0.18% | 126 |
|
|
2020
Q1 | $6.19M | Hold |
92,000
| – | – | 0.13% | 137 |
|
|
2019
Q4 | $5.03M | Buy |
92,000
+32,000
| +53% | +$1.52M | 0.09% | 155 |
|
|
2019
Q3 | $2.24M | Buy |
+60,000
| New | +$2.33M | 0.05% | 164 |
|
|
2017
Q3 | – | Sell |
-86,000
| Closed | -$1.57M | – | 202 |
|
|
2017
Q2 | $1.57M | Buy |
86,000
+46,000
| +115% | +$850K | 0.04% | 153 |
|
|
2017
Q1 | $847K | Buy |
+40,000
| New | +$781K | 0.02% | 160 |
|
Other funds holding DXCM
Handelsbanken Fonder's DXCM Position: Q2 2026 in Review
Handelsbanken Fonder reduced its DexCom (DXCM) stake by 2.8% in Q2 2026, selling an estimated $496K and leaving 262,070 shares worth $17.6M. The position accounts for 0.05% of the portfolio, ranked #294.
Handelsbanken Fonder first reported a position in DXCM in Q1 2017 and has held it in 30 quarters since. The position peaked at $62.6M in Q1 2024. 977 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.
- Handelsbanken Fonder held 262,070 shares of DexCom worth $17.6M as of Q2 2026.
- Handelsbanken Fonder sold 7,441 DexCom shares in Q2 2026, an estimated $496K.
- DexCom made up 0.05% of Handelsbanken Fonder's portfolio in Q2 2026, its #294 holding.
- Handelsbanken Fonder first reported a position in DexCom in Q1 2017 and has held it in 30 quarters since.
- Handelsbanken Fonder's DexCom position peaked at $62.6M in Q1 2024.
- 977 funds tracked by Wall St. Rank held DexCom as of Q2 2026.
Based on Handelsbanken Fonder's 13F filing for Q2 2026, filed 10 Jul 2026.